Improvement in patient-reported outcomes in rheumatoid arthritis patients treated with sarilumab is independent of the cognition levels

Joint Bone Spine. 2022 Oct;89(5):105425. doi: 10.1016/j.jbspin.2022.105425. Epub 2022 Jun 15.

¹ Rheumatology Department and CIC 1408, University Hospital of Saint Étienne, Saint-Étienne, France; SAINBIOSE INSERM, 1059, University of Lyon, Saint-Étienne, France. Electronic address: hubert.marotte@laposte.net.
² INSERM U1028 - CNRS UMR 5292, Lyon Neuroscience Research Centre, PSYR2 Team, Lyon, France; Psychiatry Department, University Hospital of Saint-Étienne, Saint-Étienne, France.
³ Rheumatology Department, University Hospital of Lille, Lille, France.
⁴ Rheumatology Department, University Hospital of Bordeaux, Bordeaux, France.
⁵ Medical Department, Sanofi Genzyme, Gentilly, France.
⁶ Sorbonne Université, INSERM, Institut Pierre Louis d'Epidémiologie et de Santé Publique, Paris, France; Rheumatology Department, Pitié Salpêtrière Hospital, AP-HP, Sorbonne Université, Paris, France.

No abstract available

Keywords: Antirheumatic agents; Arthritis; Biological therapy; Patient-reported outcomes measures; Rheumatoid arthritis.

Publication types